- Presentations
- 2
- Markets
- 2
Leqembi is a brand of Lecanemab marketed by Eisai, with 2 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lecanemab
- Brand owner
- Eisai
- Registered in
- European Union, United States
- Strengths and forms
- 200 mg/2 mL injection, 500 mg/5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Leqembi 200 mg/2 mL injectionIntravenous Cold chain | Eisai | US FDA | Available on request |
| Leqembi 500 mg/5 mL injectionIntravenous Cold chain | Eisai | US FDA | Available on request |
Equivalent brands
Other brands of Lecanemab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Leqembi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.